Episode 16

Published on:

7th Jan 2022

The surprising relationship between COVID risk & eczema

At the beginning of the pandemic, the prevailing theory was that people with eczema would be at higher risk for COVID-19 infection and impacts because so many are using steroid treatments and also suffer from asthma, which many guessed would make respiratory infections worse. But, in a rare bit of good news, the exact opposite may be true! Tune in to learn how the immune system abnormalities associated with eczema may actually protect against COVID-19 infection and how one treatment may reduce the risk of severe symptoms after infection. Our guests are Dr. Emma Guttman-Yassky, Professor of Dermatology and Immunology at the Icahn School of Medicine at Mount Sinai; Dr. Benjamin Ungar Assistant Professor of Dermatology also at Mount Sinai; and Dr. Adrian Martineau Professor of Respiratory Infection and Immunity Sciences in the School of Medicine at Queen Mary University of London.

Research referenced in this episode:

COVID-19 Symptoms in Patients Treated with Dupilumab

Risk factors for developing COVID-19

Show artwork for Eczema Breakthroughs

About the Podcast

Eczema Breakthroughs
Conversations between caregivers & the world’s cutting edge researchers.
Interviews with the leading scientists and innovators, hosted by Global Parents for Eczema Research (GPER), a non-profit led by parents of children with eczema.
Like what we're doing? Consider donating to GPER at: www.parentsforeczemaresearch.com/donate
Do you enjoy this podcast? Rate it on Apple Podcasts, Google Podcasts or Spotify!
Learn more about GPER and subscribe to this podcast at: parentsforeczemaresearch.org
Support This Show

About your host

Profile picture for korey capozza

korey capozza